Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/BBIO
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

BridgeBio Pharma Inc (BBIO) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

BridgeBio Pharma (BBIO) trades at $68.30, down 5.64% amid bearish technical signals despite strong analyst support. The biopharmaceutical company shows impressive revenue growth from $502M in 2025 to projected $713M in 2026, though it continues to post significant losses with a -144% net margin. Recent news highlights clinical successes including positive acoramidis data and Attruby sales momentum, while technical indicators show oversold conditions with RSI at 9.44.
The investment case balances strong revenue growth and promising pipeline catalysts against persistent profitability challenges. With 89% analyst buy ratings and a $110 price target representing 61% upside, the stock offers substantial potential but carries execution and cash burn risks requiring careful monitoring of clinical milestones and path to profitability.
Read full analysis

Key Stats

  • Market Cap
    $13.35B
  • Volume
    4,785,942
  • Sector
    Health
  • 52W High
    $90.17
  • 52W Low
    $49.00
  • Typical Hold Time
    63 Days
  • Enterprise Value
    $15.13B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$68.55
52W Low: $49
25 Sep 2025
52W High: $90.17
09 Jul 2026

Track BridgeBio Pharma Inc (BBIO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BridgeBio Pharma Inc has traded between a low of $49 and a high of $90.17, highlighting its annual price range. Buy and sell BridgeBio Pharma Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Most Recent News

Content is generated by Aura AI

GT Resources identifies high-priority drill target at Yukon copper-gold project using MobileMT survey

GT Resources announced that its first MobileMT geophysical survey at the CD Copper-Gold Project in Yukon identified a large, buried porphyry intrusion, a promising drill target with strong gold and copper potential. The survey revealed a resistive co...

Market News
4 hours ago
Newsfile Corp
Bullish
news icon
GT Resources identifies high-priority drill target at Yukon copper-gold project using MobileMT survey

Affirm launches new AI underwriting model approving more borrowers beyond traditional credit scores

Affirm has introduced a new transformer-based underwriting model at U.S. checkouts that evaluates credit history patterns in real time, approving borrowers its previous system would have declined, including those with thin credit files or no FICO sco...

Market News
4 hours ago
PYMNTS
Bullish
news icon
Affirm launches new AI underwriting model approving more borrowers beyond traditional credit scores

C3 Metals expands drone surveys at Khaleesi copper project after identifying large magnetic and gravity anomalies.

C3 Metals has completed and expanded drone magnetic and gravity surveys at its Khaleesi copper project in southern Peru, increasing the survey area by over 65% to 1,500 hectares due to promising results. The surveys identified multiple large-scale ma...

Market News
4 hours ago
Newsfile Corp
Bullish
news icon
C3 Metals expands drone surveys at Khaleesi copper project after identifying large magnetic and gravity anomalies.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $13.35B
  • Volume
    4,785,942
  • Sector
    Health
  • 52W High
    $90.17
  • 52W Low
    $49.00
  • Typical Hold Time
    63 Days
  • Enterprise Value
    $15.13B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$68.55
52W Low: $49
25 Sep 2025
52W High: $90.17
09 Jul 2026

Track BridgeBio Pharma Inc (BBIO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BridgeBio Pharma Inc has traded between a low of $49 and a high of $90.17, highlighting its annual price range. Buy and sell BridgeBio Pharma Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!